Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR1 | P30556 | 7/20 | 0.40 |
| ▸ | AGTR2 | P50052 | 5/20 | 0.40 |
| ▸ | PPARG | P37231 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | AVPR2 | P30518 | 1/20 | 0.34 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9708961 | 0.95 | AGTR1 (0.40) | AGTR1AGTR2PPARGKMT2ATP53 | |
| SCHEMBL9708484 | 0.92 | AGTR1 (0.43) | AGTR1AGTR2PPARGKMT2A | |
| SCHEMBL9707900 | 0.92 | AGTR1 (0.43) | AGTR1AGTR2PPARGKMT2AMEN1 | |
| SCHEMBL9708531 | 0.91 | AGTR1 (0.40) | AGTR1AGTR2PPARGKMT2AMEN1 | |
| SCHEMBL9708104 | 0.91 | AGTR1 (0.47) | AGTR1AGTR2PPARG | |
| SCHEMBL9707449 | 0.91 | KMT2A (0.45) | AGTR1AGTR2KMT2AMEN1CYP2C9 | |
| SCHEMBL9708042 | 0.91 | AGTR1 (0.36) | AGTR1AGTR2 | |
| SCHEMBL9707537 | 0.90 | AGTR1 (0.36) | AGTR1AGTR2PPARG | |
| SCHEMBL9708024 | 0.90 | AGTR1 (0.52) | AGTR1AGTR2PPARG | |
| SCHEMBL9708632 | 0.90 | AGTR1 (0.40) | AGTR1AGTR2PPARGKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1992007852-A1 | BIPHENYLALKYL XANTHINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. (US) | 1992-05-14 | — | — | WO | disclosed |